GRCL News
亘喜生物宣布正式并入阿斯利康集团
Gracell Biotechnologies Acquisition Completed
亘喜生物宣布FasTCAR-T GC012F早线治疗多发性骨髓瘤的1期新药临床试验（IND）申请获美国FDA批准
Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates AMAM, AXNX, HARP, GRCL
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates GRCL, RYZB, CPE, BRBS
Kuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to Contact Law Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RYZB, KRTX, GRCL
GRCL Events
No data
GRCL Monitor News
No data
GRCL Earnings Analysis